RERBX
Price
$54.18
Change
-$0.50 (-0.91%)
Updated
Feb 21 closing price
Net Assets
131.04B
TWGAX
Price
$13.12
Change
-$0.15 (-1.13%)
Updated
Feb 21 closing price
Net Assets
2.71B
Ad is loading...

RERBX vs TWGAX

Header iconRERBX vs TWGAX Comparison
Open Charts RERBX vs TWGAXBanner chart's image
American Funds Europacific Growth R2
Price$54.18
Change-$0.50 (-0.91%)
VolumeN/A
Net Assets131.04B
American Century International Gr A
Price$13.12
Change-$0.15 (-1.13%)
VolumeN/A
Net Assets2.71B
RERBX vs TWGAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RERBX vs. TWGAX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RERBX is a Hold and TWGAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RERBX has more cash in the bank: 131B vs. TWGAX (2.71B). RERBX pays higher dividends than TWGAX: RERBX (1.00) vs TWGAX (0.23). RERBX was incepted earlier than TWGAX: RERBX (23 years) vs TWGAX (28 years). TWGAX is a more actively managed with annual turnover of: 54.00 vs. RERBX (34.00). RERBX has a lower initial minimum investment than TWGAX: RERBX (250) vs TWGAX (2500). TWGAX annual gain was more profitable for investors over the last year : 4.67 vs. RERBX (0.62). RERBX return over 5 years is better than : 4.32 vs. TWGAX (2.45).
RERBXTWGAXRERBX / TWGAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years28 years-
Gain YTD6.5496.235105%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets131B2.71B4,832%
Annual Yield % from dividends1.000.23441%
Returns for 1 year0.624.6713%
Returns for 3 years-0.322.51-13%
Returns for 5 years4.322.45176%
Returns for 10 years15.575.33292%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KFS7.66-0.01
-0.13%
Kingsway Financial Services
ENLV1.00-0.02
-1.81%
Enlivex Therapeutics Ltd
PGRE4.52-0.10
-2.16%
Paramount Group
PTC161.65-4.11
-2.48%
PTC
RNA31.12-1.41
-4.33%
Avidity Biosciences